Legal Representation
Attorney
Karen L. Elbing
USPTO Deadlines
Next Deadline
1090 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-07-03)
Due Date
July 03, 2028
Grace Period Ends
January 03, 2029
Application History
50 eventsDate | Code | Type | Description |
---|---|---|---|
Jan 17, 2025 | C71T | O | CANCELLED SECTION 71 |
Dec 26, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Jul 3, 2023 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Mar 11, 2023 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Feb 11, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Jun 4, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Mar 19, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
May 17, 2019 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Feb 1, 2019 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Nov 2, 2018 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
Oct 12, 2018 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
Oct 12, 2018 | FIMP | P | FINAL DISPOSITION PROCESSED |
Oct 3, 2018 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Jul 10, 2018 | CORR | I | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
Jul 10, 2018 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED |
Jul 3, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Jun 15, 2018 | GPNX | P | NOTIFICATION PROCESSED BY IB |
Jun 8, 2018 | RINX | P | USPTO CORRECTION PROCESSED BY IB |
Jun 8, 2018 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB |
Apr 17, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Apr 17, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
Mar 28, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 28, 2018 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Mar 28, 2018 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Mar 9, 2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Mar 9, 2018 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
Mar 9, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Mar 9, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Mar 9, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Mar 1, 2018 | RDX1 | O | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED |
Mar 1, 2018 | RDX3 | O | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED |
Mar 1, 2018 | RRDX | W | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED |
Feb 14, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 14, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Feb 14, 2018 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Sep 12, 2017 | GNFR | O | FINAL REFUSAL E-MAILED |
Sep 12, 2017 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
Sep 12, 2017 | CNFR | R | FINAL REFUSAL WRITTEN |
Aug 23, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Aug 22, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Aug 22, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jun 29, 2017 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jun 29, 2017 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Apr 3, 2017 | CRSN | M | CORRECTION SENT TO IB |
Apr 3, 2017 | CRCR | E | CORRECTION CREATED FOR IB |
Mar 25, 2017 | RFNT | P | REFUSAL PROCESSED BY IB |
Mar 3, 2017 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Mar 3, 2017 | RFRR | P | REFUSAL PROCESSED BY MPU |
Mar 2, 2017 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Mar 1, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN |
Additional Information
Design Mark
The mark consists of four incomplete rectangles with curved edges in a two-by-two orientation with the top left, bottom left, and bottom right having the open ends facing left while the top right has the open end facing right.
Color Claim
Color is not claimed as a feature of the mark.
Other
In the Heading and In the Statement, Int. Cls. 5 "Orthopedic wound dressings" should be inserted, and, In the Statement, Page 1, lines 15 and 16, "orthopedic wound dressings," should be deleted.
Pseudo Mark
3S; BS